Investor Presentation 16 May 2016
Download the Investor Presentation available on Google Drive and ASX.
ASX Announcements
InvitroCue Announces Malaria Initiative
May 16, 2016 – InvitroCue (ASX:IVQ), a leader in advanced bio-analytics, announces today a key initiative on Malaria to identify and evaluate new drug targets to tropical infectious diseases. Following its successful initiative on leishmaniasis, InvitroCue establishes an open and collaborative strategy that involves integrated partnerships and networks between academic infectious diseases institutes and pharmaceutical …
InvitroCue Expands 3D Cell-based Platform for Oncology
May 12, 2016 – InvitroCue (ASX:IVQ), a leader in advanced bio-analytics, announces today that it is planning to enter the oncology testing market for drugs to provide data points in selected solid tumours. Using its revolutionary 3D cell-based technology and proprietary processes, InvitroCue will be able to culture patient derived cancer cells in its laboratories …
Appendix 4C – Quarterly Report
Quarterly Report – Appendix 4C
New Issue Announcement
New Issue Announcement, Application for Quotation of Additional Securities and Agreement : Appendix 3B
Initial Director's Interest Notice
Appendix 3x : Initial Director’s Interest Notice Initial Director’s Interest Notice
New Issue Announcement
Appendix 3B : New Issue Announcement Appendix 3B
Becoming a Substantial Holder – Steven Fang
Form 603 : Notice of Initial Substantial Holder Steven Fang
Agreement with London School of Hygiene & Tropical Medicine
Download the InvitroCue Agreement PDF here: Agreement
Operations Update
Download the InvitroCue Operations Update PDF here: InvitroCue Operations Update